The value of Pre-Ablative I-131 scan for clinical management in patients with differentiated thyroid carcinoma
T van der Boom, WT Zandee, CCJ Dekkers… - Frontiers in …, 2021 - frontiersin.org
Background A diagnostic I-131 (Dx) scan is used to detect a thyroid remnant or metastases
before treatment of differentiated thyroid cancer (DTC) with I-131. The aim of this study is to …
before treatment of differentiated thyroid cancer (DTC) with I-131. The aim of this study is to …
Preablation 131-I scans with SPECT/CT contribute to thyroid cancer risk stratification and 131-I therapy planning
AM Avram, NH Esfandiari… - The Journal of Clinical …, 2015 - academic.oup.com
Context: The use of preablation diagnostic radioiodine scans for risk stratification and
radioiodine therapy planning for differentiated thyroid cancer (DTC) remains controversial …
radioiodine therapy planning for differentiated thyroid cancer (DTC) remains controversial …
Prognostic Impact of Direct 131I Therapy After Detection of Biochemical Recurrence in Intermediate or High-Risk Differentiated Thyroid Cancer: A Retrospective …
JF Carrillo, R Vázquez-Romo… - Frontiers in …, 2019 - frontiersin.org
Background: Patients treated for intermediate-or high-risk differentiated thyroid carcinoma
(DTC) and Thyroglobulin (TG) elevation during follow-up, require a diagnostic whole-body …
(DTC) and Thyroglobulin (TG) elevation during follow-up, require a diagnostic whole-body …
[PDF][PDF] Diagnostic whole-body scan may not be necessary for intermediate-risk patients with differentiated thyroid cancer after low-dose (30 mCi) radioactive iodide …
EJ Jeon, E Dal Jung - Endocrinology and Metabolism, 2014 - synapse.koreamed.org
Background: A diagnostic whole-body scan (WBS) is recommended 6 to 12 months after
total thyroidectomy and radioactive iodide ablation in intermediate-or high-risk patients with …
total thyroidectomy and radioactive iodide ablation in intermediate-or high-risk patients with …
Radioiodine in differentiated thyroid carcinoma: do we need diagnostic pre-ablation iodine-123 scintigraphy to optimize treatment?
EJ de Koster, T Sulaiman, JF Hamming, A Schepers… - Diagnostics, 2021 - mdpi.com
Changing insights regarding radioiodine (I-131) administration in differentiated thyroid
carcinoma (DTC) stir up discussions on the utility of pre-ablation diagnostic scintigraphy …
carcinoma (DTC) stir up discussions on the utility of pre-ablation diagnostic scintigraphy …
Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole‐body …
M Salvatori, G Perotti, V Rufini… - Clinical …, 2004 - Wiley Online Library
Summary objective To evaluate the risk of performing inappropriate 131I ablative therapies
for thyroid carcinoma in patients lacking thyroid remnants or metastases, using a strategy of …
for thyroid carcinoma in patients lacking thyroid remnants or metastases, using a strategy of …
Long-Term Survival in Differentiated Thyroid Cancer Is Worse After Low-Activity Initial Post-Surgical 131I Therapy in Both High- and Low-Risk Patients
FA Verburg, U Mäder, C Reiners… - The Journal of Clinical …, 2014 - academic.oup.com
Context: Recent trial results have revived interest in low-activity initial 131I therapy (RIT) of
differentiated thyroid cancer (DTC). Objective: This study sought to compare different initial …
differentiated thyroid cancer (DTC). Objective: This study sought to compare different initial …
Pre-Treatment and Post-Treatment I-131 Imaging in Differentiated Thyroid Carcinoma
J Mihailović - Journal of Clinical Medicine, 2024 - mdpi.com
Radioiodine imaging in initial perioperative settings, after the total thyroidectomy, includes
pre-treatment and post-treatment radioiodine imaging. While the benefit of post-treatment …
pre-treatment and post-treatment radioiodine imaging. While the benefit of post-treatment …
Impact factors of benefiting from initial 131I ablation in patients with intermediate-risk differentiated thyroid carcinoma: a study based on a re-evaluation of therapeutic …
L Ren, Y Hu, Y Hu, D Xiao, J Sun, B Zhu… - Nuclear Medicine …, 2024 - journals.lww.com
Objective This study was carried out to confirm whether patients with intermediate-risk
differentiated thyroid cancer (DTC) could benefit from initial 131 I ablation and to identify the …
differentiated thyroid cancer (DTC) could benefit from initial 131 I ablation and to identify the …
Patients with high‐risk differentiated thyroid cancer have a lower I‐131 ablation success rate than low‐risk ones in spite of a high ablation activity
J Winter, M Winter, T Krohn, A Heinzel… - Clinical …, 2016 - Wiley Online Library
Objective To examine success rates in strictly defined high‐risk differentiated thyroid cancer
(DTC) patients who received a high‐activity (≥ 5550 MB q) adjuvant postoperative I‐131 …
(DTC) patients who received a high‐activity (≥ 5550 MB q) adjuvant postoperative I‐131 …